The HIV In-home Test Tax Exemption Amendment Act of 2025 aims to amend section 47-2005 of the District of Columbia Official Code by exempting sales of HIV in-home tests from taxation. This legislation is introduced to enhance accessibility to HIV testing for District residents, as the cost of these tests ranges from $40 to $70, which can be a financial burden for many. The bill emphasizes the importance of knowing one's HIV status and starting treatment to prevent the spread of the virus and improve public health outcomes.

The new legal language added to the current law specifies that sales of human immunodeficiency virus (HIV) in-home tests will be exempt from taxation. The bill outlines the applicability of the act, which will take effect once its fiscal impact is included in an approved budget and financial plan. Additionally, it includes provisions for the certification of this inclusion by the Chief Financial Officer and the subsequent publication of the notice in the District of Columbia Register. The act will become effective following the Mayor's approval and a 30-day congressional review period.